IL17A and myocardial infarction: Yan et al (17) reported almost the same findings in a mouse model of acute myocardial infarction, where they demonstrated increased survival after day 7 in mice lacking either interleukin 23 (IL-23), IL-17A, or T-cell receptor gamma delta (TCRγδ) positive T-cells.